España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lyra Therapeutics
LYRA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1800
0.01000
5.88%
At close: -
$0.1830
0.00300
1.67%
After Hours: Dec 20, 7:31 PM EDT
Get Report
Comment
Lyra Therapeutics (LYRA) Forecast
News
Earnings
Lyra Therapeutics (LYRA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lyra Therapeutics (NASDAQ:LYRA) Stock
Lyra Therapeutics Stock (NASDAQ: LYRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
Lyra Therapeutics shares are trading lower af...
Benzinga Newsdesk
Tuesday, November 12, 2024
Lyra Therapeutics Q3 2024 GAAP EPS $(0.18) Be...
Benzinga Newsdesk
Tuesday, October 15, 2024
Lyra Therapeutics Completes Enrollment For Pi...
Benzinga Newsdesk
Friday, September 27, 2024
Lyra Therapeutics Announced That The Company Will Present Results From The Phase 3 ENLIGHTEN 1 Study For LYR-210, The Company's Lead Product Candidate For CRS
Nabaparna Bhattacharya
Thursday, August 15, 2024
Cantor Fitzgerald Reiterates Overweight on Ly...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Lyr...
Benzinga Newsdesk
Wednesday, August 14, 2024
Lyra Therapeutics Q2 EPS $(0.74) Misses $(0.3...
Benzinga Newsdesk
Wednesday, July 17, 2024
Lyra Therapeutics Granted U.S. Patent #120363...
Benzinga Newsdesk
Thursday, June 20, 2024
Lyra Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ly...
Benzinga Newsdesk
Friday, June 07, 2024
Lyra Therapeutics Estimates That It Will Incu...
Benzinga Newsdesk
Tuesday, May 21, 2024
Trading Halt: Halt status updated at 9:40:00 ...
Benzinga Newsdesk
Lyra Therapeutics Implementing Layoff Of ~75%...
Benzinga Newsdesk
Trading Halt: Halted at 8:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, May 14, 2024
New Post-Hoc Analysis Of Pooled Phase 3 Data ...
Benzinga Newsdesk
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Where Lyra Therapeutics Stands With Analysts
Benzinga Insights
HC Wainwright & Co. Downgrades Lyra Therapeut...
Benzinga Newsdesk
Lyra Therapeutics shares are trading lower on...
Benzinga Newsdesk
Jefferies Downgrades Lyra Therapeutics to Hol...
Benzinga Newsdesk
Monday, May 06, 2024
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
Avi Kapoor
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
BTIG Downgrades Lyra Therapeutics to Neutral
Benzinga Newsdesk
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
Avi Kapoor
Why Lyra Therapeutics Stock Is Down 93% Today
Henry Khederian
Lyra Therapeutics shares are trading lower af...
Benzinga Newsdesk
Lyra Therapeutics Shares Resume Trade
Benzinga Newsdesk
Trading Halt: Halt status updated at 8:25:00 ...
Benzinga Newsdesk
Lyra Therapeutics Reports Topline Results Fro...
Benzinga Newsdesk
Trading Halt: Halted at 7:50:00 a.m. ET - Tra...
Benzinga Newsdesk
Wednesday, May 01, 2024
HC Wainwright & Co. Reiterates Buy on Lyra Th...
Benzinga Newsdesk
Tuesday, April 30, 2024
Lyra Therapeutics Q1 EPS $(0.35) Misses $(0.2...
Benzinga Newsdesk
Wednesday, April 17, 2024
Cantor Fitzgerald Reiterates Overweight on Ly...
Benzinga Newsdesk
Monday, March 25, 2024
B of A Securities Maintains Buy on Lyra Thera...
Benzinga Newsdesk
Friday, March 22, 2024
HC Wainwright & Co. Reiterates Buy on Lyra Th...
Benzinga Newsdesk
Tuesday, November 14, 2023
Executive Chair of Lyra Therapeutics Purchased $74K In Stock
Benzinga Insights
Friday, October 06, 2023
What 4 Analyst Ratings Have To Say About Lyra Therapeutics
Benzinga Insights
BTIG Assumes Lyra Therapeutics at Buy, Announ...
Benzinga Newsdesk
Monday, October 02, 2023
HC Wainwright & Co. Reiterates Buy on Lyra Th...
Benzinga Newsdesk
Tuesday, September 12, 2023
B of A Securities Maintains Buy on Lyra Thera...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Lyra Therapeutics shares are trading higher a...
Benzinga Newsdesk
Market-Moving News for September 12th
Benzinga Newsdesk
Lyra Therapeutics Shares Resume Trade
Bill Haddad
Lyra Therapeutics' BEACON Phase 2 Study Of LY...
Benzinga Newsdesk
Thursday, August 31, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Lyr...
Benzinga Newsdesk
Tuesday, August 29, 2023
Lyra Therapeutics Announced That The Pivotal ...
Benzinga Newsdesk
Thursday, July 13, 2023
Lyra Therapeutics President & CEO Awarded $468K Worth of Stock Options
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch